Clinical Trial Update: Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating erythropoietin to protect renal function after cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Renal Failure

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Region Skane | Conditions: Kidney Failure, Renal Failure | Phase 2 | Status: COMPLETED